19 completed, 10 unknown, 6 recruiting, 4 terminated. 11 Not applicable, 5 Phase 1, 5 Phase 2, 5 Phase 4, 3 Phase 3.
Follow Virilism: new trials by email Literature Review of Virilism trials Research Report on Virilism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS) Beef+ - PCOS (Polycystic Ovary Syndrome), Obese Adolescents | Not applicable | Recruiting | Texas A&M University | 36 | 2026-09-01 | 2026-08-21 |
| Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS) Magnesium 500 mg, Levocarnitine 1000 mg, Placebo - Polycystic Ovary Syndrome (PCOS) | Not applicable | Recruiting | Behnood Abbasi | 84 | 2026-01-30 | 2025-12-23 |
| Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female Eflornithine Topical, Instense pulsed light - Hirsuitism | Phase 4 | Recruiting | Khyber Teaching Hospital | 122 | 2025-07-15 | 2025-07-03 |
| The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the s, Placebo - PCO - Polycystic Ovaries, Obesity and Obesity-related Medical Conditions | Phase 1 | Recruiting | Isfahan University of Medical Sciences | 44 | 2024-07-22 | 2024-10-17 |
| Diagnostics of Clinical Hyperandrogenism Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale, Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale - Anovulation, PCOS | Completed | Jagiellonian University | 1330 | 2024-02-29 | 2026-04-02 | |
| Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder intense pulsed light - Excessive Hairiness, Vascular Lesion | Not applicable | Recruiting | Eurofeedback | 85 | 2024-01-20 | 2024-10-23 |
| Treatment of Hypertrichosis With Intense Pulsed Light Intense pulsed light - Hypertrichosis, Hirsutism - Hypertrichosis | Recruiting | Alexander Shayesteh | 39 | 2023-12-01 | 2025-04-08 | |
| Suppression of Upper Lip Hair Growth Using Novel Hemp Extract Narcissus Tazetta Bulb Extract and Novel Hemp Extract - Hirsutism, Hair Diseases | Unknown | Medical Life Care Planners, LLC | 25 | 2023-09-01 | 2023-08-21 | |
| Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study. Diagnostic Ultrasound, Venous puncture - Polycystic Ovary Syndrome, Hyperandrogenism | Unknown | Instituto de fertilidad humana, InSer | 626 | 2023-03-04 | 2023-07-03 | |
| To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted Hair IPL, Diode - Hirsuitism | Not applicable | Completed | Combined Military Hospital Abbottabad | 60 | 2022-05-11 | 2023-02-22 |
| The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics Yasmin, Diane-35 - Polycystic Ovary Syndrome | Not applicable | Unknown | Inonu University | 42 | 2021-03-01 | 2022-05-19 |
| Prevalence of Hyperandrogenism in Type 1 Diabetes Clinical hyperandrogenism assessment, Total testosterone (ng/dL), A1c (%) - Type 1 Diabetes, Polycystic Ovary Syndrome | Completed | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 150 | 2020-03-09 | 2025-03-17 | |
| Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group Hirsutism | Unknown | Istanbul Medeniyet University | 5861 | 2020-02-03 | 2020-03-03 | |
| Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Myo-inositol+L-tyrosine - Polycystic Ovary Syndrome, Menstrual Problem | Not applicable | Completed | Pharmarte srl | 186 | 2017-05-02 | 2020-06-16 |
| MLE4901 vs. Placebo for the Treatment of PCOS MLE4901, Placebo - Polycystic Ovary Syndrome (PCOS) | Phase 2 | Terminated | Millendo Therapeutics US, Inc. | 55 | 2016-07-01 | 2021-02-01 |
| Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth FOL-005, Placebo - Hypertrichosis, Alopecia | Phase 1 / Phase 2 | Completed | Follicum AB | 44 | 2016-01-01 | 2017-08-01 |
| DUS on the Prescribing Indications for CPA/EE in 5 European Countries Hirsutism, Androgenetic Alopecia | Completed | Center for Epidemiology and Health Research, Germany | 1597 | 2015-03-06 | 2021-08-27 | |
| Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS) Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) - Polycystic Ovary Syndrome, PCOS | Not applicable | Terminated | Nationwide Children's Hospital | 12 | 2014-01-01 | 2019-10-07 |
| Clinical Evaluation of Silk'n Glide for Face Glide - Hirsutism | Not applicable | Completed | Home Skinovations Ltd. | 17 | 2013-09-01 | 2018-09-10 |
| NAFLD in Adolescents and Young Adults With PCOS Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease | Suspended | Columbia University | 80 | 2013-07-01 | 2026-09-30 |
Showing 20 of 40. Sign in to see all of them.
Hirsutism (40) · Polycystic Ovary Syndrome (17) · Hyperandrogenism (8) · Hypertrichosis (5) · Menstruation Disturbances (5) · Acne Vulgaris (4) · Alopecia (4) · Amenorrhea (4) · Insulin Resistance (4) · ACTH Syndrome, Ectopic (3) · Adrenal Cortex Neoplasms (3) · Anovulation (3) · Choristoma (3) · Cushing Syndrome (3) · Dyslipidemias (3)
Pathological Conditions, Signs and Symptoms (40) · Signs and Symptoms (40) · Skin Diseases (40) · Skin and Connective Tissue Diseases (40) · Hair Diseases (39) · Neoplasms (22) · Endocrine System Diseases (20) · Genital Diseases (20) · Urogenital Diseases (20) · Adnexal Diseases (18) · Female Urogenital Diseases (18) · Female Urogenital Diseases and Pregnancy Complications (18) · Genital Diseases, Female (18) · Gonadal Disorders (18)
Eflornithine (3) · Intense Pulsed Light Therapy (3) · Corlux (2) · Metformin (2) · Mifepristone (2) · bicalutamide (2) · Body Composition (1) · Body Mass Index (1) · Cardiovascular Physiological Phenomena (1) · Carnitine (1) · Cyproterone Acetate (1) · Cyproterone acetate, ethinyl estradiol drug combination (1) · Ethinyl Estradiol (1) · Flutamide (1) · Folic Acid (1)
Corcept Therapeutics (3) · Odense University Hospital (3) · Columbia University (2) · Sandoz (2) · Scilex Ltd. (2) · Alexander Shayesteh (1) · Allergan (1) · Behnood Abbasi (1) · Bispebjerg Hospital (1) · Catholic University of the Sacred Heart (1) · Center for Epidemiology and Health Research, Germany (1) · Combined Military Hospital Abbottabad (1) · Eurofeedback (1) · Follicum AB (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1)
United States (9) · Denmark (4) · Germany (3) · Iran (2) · Israel (2) · Italy (2) · Pakistan (2) · Spain (2) · Turkey (Türkiye) (2) · Colombia (1) · France (1) · Norway (1) · Poland (1) · Sweden (1) · Taiwan (1)
Coleman Gross, MD (2) · Leon Gilad, MD (2) · Richard Larouche, M.D. (2) · Adam Gilmour, MBChB, MRCS (Ed) (1) · Aviva B Sopher, MD, MS, MS (1) · Aviva Sopher, MD, MS, MS (1) · Coleman Gross (1) · Daniel Dumesic, MD (1) · Dorte Glintborg, MD (1) · Elisabeth H Taudorf, MD (1) · Filiz Cebeci Kahraman, Assoc. Prof. (1) · Heidi K Vanden Brink, PhD, MSc, RDMS (1) · Iain Mackay, MBChb, MRCS, FRCS (plast) (1)
PMID 25013998, PMID 26507877, PMID 17536071, PMID 18375410, PMID 18997670, PMID 20730705, PMID 22168920, PMID 22341881, PMID 22466348, PMID 22693172, PMID 23970725, PMID 25003376, PMID 36400597
2004 (1), 2016 (1)